Skip to main content
Equibles

Woodline Partners LP

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1784547 San Francisco, CA
Back to AVBP Full portfolio

Position in AVBP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,128,978
+$1,722,947 QoQ
Shares Held
147,639
0.0% QoQ
Ownership
0.299%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#36
of 158 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. AVBP ranks #133 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in AVBP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,128,978 147,639
2026-03-31 $3,406,031 147,639
2025-12-31 $2,965,406 147,386
2025-09-30 $5,478,100 296,916
2025-06-30 $3,198,361 146,916
2025-03-31 $2,706,436 146,373
2024-12-31 $3,884,032 145,797
2024-09-30 $2,842,184 120,944
2024-06-30 $1,855,000 100,000
2024-03-31 $1,786,000 100,000